Jo Ellen Schweinle

RenovaCare Chief Medical Officer Dr. Jo Ellen Schweinle is an accomplished physician, scientist, and clinical investigator, with more than 30 years of medical, regulatory, and clinical trial expertise from global healthcare organizations and some of the world’s leading government and commercial teams.

Prior to her appointment at RenovaCare, Dr. Schweinle served as Senior Medical Officer at the U.S. Department of Health and Human Services; and in the private sector as Senior Clinical Director at Bayer Corporation, GlaxoSmithKline, McNeil Pharmaceuticals, Chiron/Novartis, and VP Medical Affairs at Axcan Pharma.

Dr. Schweinle is a renowned medical voice and noted authority in the use of self-donated stem cells and burn therapies, cornerstones of the RenovaCare CellMist™ and SkinGun™ technologies for the isolation and spray of a patient’s own cells onto burns and wounds.

Dr. Schweinle has led and managed numerous worldwide clinical studies. In her most recent role at U.S. Health and Human Services, she provided her clinical acumen towards the clinical development of a wide array of burn wound product candidates including therapeutics, debridement agents, and medical imaging devices.

Her addition to the Executive Leadership Team strengthens The RenovaCare clinical and regulatory programs for an investigation into new and promising cell therapies using skin and other tissue sources and the patented CellMist System™ and SkinGun™ device.

Dr. Schweinle is the recipient of numerous honors and grants. She began her career teaching and researching infectious diseases at the University of Texas, National Institutes of Health, and Yale University School of Medicine. She has been published in major scientific journals including Clinical Infectious Diseases, Health Security, Vaccine, and Epidemiol.